VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASPN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ASPNAspen Aerogels, Inc.
$5.98$496M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksASPNBalance Sheet

Aspen Aerogels, Inc. (ASPN) Balance Sheet

16Y historyFree accessUpdated daily

The company maintains a debt-to-equity ratio of 0.60, though the long-term accumulation of losses has resulted in a significant retained earnings deficit of $1.1B.

ASPN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'10Dec'09
Total Current Assets252.55M242.05M409.45M266.33M369.69M112.15M47.12M45.77M37.25M47.66M50.19M61.65M73.38M28.09M22.28M43.82M33.79M
Cash & Short-Term Investments175.58M156.86M220.88M139.72M281.33M76.56M16.5M3.63M3.33M10.69M18.09M32.8M49.72M1.57M1.34M30.82M27.5M
Cash Only175.58M156.86M220.88M139.72M281.33M76.56M16.5M3.63M3.33M10.69M18.09M32.8M49.72M1.57M1.34M26.8M27.5M
Short-Term Investments0000000000000004.02M0
Accounts Receivable36.44M35.27M109.1M70M57.35M20.43M15.7M32.25M25.57M26.76M17.54M20.62M17.92M18.76M14.16M10.21M4.23M
Days Sales Outstanding8647.4987.97107.02116.0661.357.1484.4789.4187.5154.3661.4463.8979.5481.4686.254.01
Inventory31.05M38.25M47.55M39.19M22.54M11.99M13.1M8.77M7.32M8.91M12.87M6.53M4.9M6.89M6.34M2.25M1.6M
Days Inventory Outstanding7462.0264.3378.6846.939.1755.828.329.133549.7424.3620.9533.3832.4321.9218.12
Other Current Assets9.47M11.68M31.91M17.42M8.46M001.11M1.04M1.29M1.7M0000124K100K
Total Non-Current Assets157.93M164.63M485.7M436.72M273.73M70.8M50.3M57.73M61.77M76.15M84.48M78.43M71.67M62.35M73.03M44.97M30.94M
Property, Plant & Equipment116.62M122.55M480.13M434.44M271.21M69.31M50.22M57.65M61.7M76.07M84.39M78.32M71.49M62.02M72.64M42.62M29.76M
Fixed Asset Turnover1.54x2.21x0.94x0.55x0.67x1.75x2.00x2.42x1.69x1.47x1.40x1.56x1.43x1.39x0.87x1.01x0.96x
Goodwill00000000000000000
Intangible Assets00000000000000000
Long-Term Investments00000000000000000
Other Non-Current Assets41.31M42.08M5.57M2.28M2.52M1.5M84K84K73K86K89K105K175K331K390K2.35M1.18M
Total Assets410.48M406.68M895.14M703.05M643.42M182.95M97.42M103.5M99.02M123.81M134.67M140.07M145.04M90.44M95.3M88.8M64.73M
Asset Turnover0.50x0.67x0.51x0.34x0.28x0.66x1.03x1.35x1.05x0.90x0.87x0.87x0.71x0.95x0.67x0.49x0.44x
Asset Growth %-147.67%-54.57%27.32%9.27%251.68%87.79%-5.87%4.52%-20.02%-8.06%-3.86%-3.43%60.37%-5.1%7.33%37.17%-
Total Current Liabilities87.8M62.02M110.11M78.09M78.94M36.55M13.93M30.43M23.07M21.57M18.13M17.41M20.21M31.55M21.14M19.1M12.03M
Accounts Payable13.61M13.24M44.36M51.09M54.73M17.44M5.35M12.6M12.39M10.65M13.06M10.68M14.2M7.11M9.08M5.6M2.93M
Days Payables Outstanding32.8321.4760.01102.58113.895722.840.6549.3341.8350.539.8560.7634.4546.4154.4533.13
Short-Term Debt34.25M34.57M23.78M0001.61M3.12M4.18M3.75M00018.74M1.34M247K262K
Deferred Revenue (Current)23.85M1.26M2.2M2.32M5.85M6.05M2.04M5.62M2.63M1.3M1.04M681K292K595K1.18M447K630K
Other Current Liabilities11.74M12.95M19.37M16.88M12.47M8.99M2.59M1.58M1.11M1.23M1.19M1.79M4.9M1.1M8.02M6.8M7.4M
Current Ratio2.88x3.90x3.72x3.41x4.68x3.07x3.38x1.50x1.61x2.21x2.77x3.54x3.63x0.89x1.05x2.29x2.81x
Quick Ratio2.52x3.29x3.29x2.91x4.40x2.74x2.44x1.22x1.30x1.80x2.06x3.17x3.39x0.67x0.75x2.18x2.68x
Cash Conversion Cycle127.1788.0392.2883.1249.0743.4890.1572.1169.2180.6953.645.9624.0878.4767.4853.6739
Total Non-Current Liabilities109.18M109.14M170.33M136.9M117.04M17.99M15.64M14.08M5.7M1.3M975K191K1.12M120.86M108.7M127.8M46.56M
Long-Term Debt68.31M79.8M137.09M114.99M103.58M02.06M000000119.57M108.62M7.82M247K
Capital Lease Obligations118.24M29.34M33.23M21.91M13.46M12.99M3.6M4.29M004K40K89K165K79K52K51K
Deferred Tax Liabilities000000434K-9.79M000000000
Other Non-Current Liabilities00000009.79M5.7M1.3M971K151K1.03M1.12M0119.93M46.26M
Total Liabilities196.98M171.16M280.44M214.99M195.98M54.55M29.57M44.51M28.77M22.87M19.11M17.6M21.33M152.41M129.85M146.9M58.58M
Total Debt128.82M143.71M197.38M138.77M119.4M15.24M8.31M8.45M4.18M3.75M39K107K165K138.56M110.08M8.14M575K
Net Debt-46.76M-13.15M-23.5M-951K-161.93M-61.33M-8.19M4.82M854K-6.94M-18.05M-32.7M-49.55M136.98M108.74M-18.66M-26.93M
Debt / Equity0.60x0.61x0.32x0.28x0.27x0.12x0.12x0.14x0.06x0.04x0.00x0.00x0.00x---0.09x
Debt / EBITDA0.47x-2.50x--------0.03x-----
Net Debt / EBITDA-0.17x--0.30x---------8.95x-----
Interest Coverage-17.60x0.94x2.26x-7.60x-15.19x-160.98x-89.87x-34.87x-64.73x-103.44x-76.33x-34.26x-0.32x-0.56x-1.58x-2.90x-5.07x
Total Equity213.5M235.52M614.71M488.06M447.44M128.41M67.85M58.99M70.25M100.94M115.56M122.47M123.72M-61.97M-34.55M-58.1M6.15M
Equity Growth %-174.02%-61.69%25.95%9.08%248.45%89.25%15.02%-16.03%-30.4%-12.65%-5.64%-1%299.65%-79.38%40.55%-1044.3%-
Book Value per Share2.582.857.657.0311.374.222.572.452.964.324.995.335.38-2.69-2.24-3.760.40
Total Shareholders' Equity213.5M235.52M614.71M488.06M447.44M128.41M67.85M58.99M70.25M100.94M115.56M122.47M123.72M-61.97M-34.55M-58.1M6.15M
Common Stock00000000000000026K26K
Retained Earnings-1.07B-1.05B-660.23M-673.6M-627.79M-545.05M-507.96M-486.15M-471.58M-437.14M-417.52M-405.5M-399.08M-332.76M-285.15M-196.18M-186.26M
Treasury Stock00000000000000000
Accumulated OCI00000000-92.7M-82.53M-71.98M-62.25M0-43.22M-36.56M8K0
Minority Interest00000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Manufacturing scale-up execution risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Contraction Following Expansion

As reported in recent financial statements, total assets have declined from a peak of $895.1M in 2024Q4 to $410.5M in 2026Q1, signaling a significant recalibration of the company's capital footprint as it navigates the transition from heavy infrastructure investment to operational scaling.

The reduction in total assets appears to reflect the completion of major capital projects and a potential write-down or rationalization of the asset base. Investors should monitor whether this contraction represents a permanent shift toward a leaner operating model or a forced divestment due to persistent operational losses.

Leverage Managed Amidst Operational Losses

Based on the latest quarterly filings, the company maintains a debt-to-equity ratio of 0.60, which suggests that management has successfully avoided excessive leverage despite the substantial capital requirements needed to support the ongoing pivot toward the electric vehicle thermal barrier market segment.

While the debt load remains manageable relative to equity, the reliance on external financing to bridge the gap between R&D spending and commercial revenue warrants caution. The stability of this leverage ratio depends heavily on the company's ability to reach cash-flow break-even before further capital infusions are required.

Liquidity Buffer Supports Operational Runway

According to recent SEC filings, the company holds $175.6M in cash as of 2026Q1, providing a current ratio of 2.88 that appears sufficient to sustain near-term operations while the firm continues to navigate the volatile ramp-up of its specialized manufacturing facilities.

The current liquidity position provides a necessary cushion against the ongoing cash burn observed in the income statement. However, the sustainability of this buffer is contingent upon the successful conversion of EV supply agreements into consistent, high-margin revenue streams.

Accumulated Deficit Weighs on Equity

As indicated by the company's balance sheet, retained earnings have deteriorated to a deficit of $1.1B as of 2026Q1, reflecting the long-term impact of persistent net losses and the high costs associated with developing proprietary aerogel technology for industrial and automotive applications.

The significant erosion of retained earnings highlights the historical difficulty in achieving profitability, which may limit the company's ability to return value to shareholders in the near term. This trend underscores the necessity for a successful transition to high-volume production to reverse the ongoing depletion of equity.

Asset Quality and Impairment Risks

Based on reported figures, the net PPE value has decreased from $480.1M in 2024Q4 to $116.6M in 2026Q1, which may indicate aggressive depreciation or potential asset impairments that could mask the true underlying health of the company's manufacturing infrastructure.

The rapid decline in net PPE warrants further investigation into whether these assets are being utilized effectively or if they are becoming obsolete due to rapid changes in battery technology. Investors should be wary of the potential for future write-downs if the current manufacturing capacity fails to meet projected demand.

ASPN — Frequently Asked Questions

Quick answers to the most common questions about buying ASPN stock.

What are the total assets of Aspen Aerogels, Inc. (ASPN)?

As of 2025, Aspen Aerogels, Inc. (ASPN) had total assets of $406.7M including $242.1M in current assets.

How much debt does Aspen Aerogels, Inc. (ASPN) have?

Aspen Aerogels, Inc. (ASPN) carries total debt of $143.7M, offset by $156.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Aspen Aerogels, Inc.?

Aspen Aerogels, Inc. (ASPN) has total shareholders' equity (book value) of $235.5M ($2.85 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Aspen Aerogels, Inc.'s current ratio and liquidity?

Aspen Aerogels, Inc. (ASPN) reported a current ratio of 3.90x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.